Shopping Cart
- Remove All
- Your shopping cart is currently empty
MRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $338 | In Stock | |
5 mg | $713 | In Stock | |
10 mg | $1,130 | In Stock | |
25 mg | $1,690 | In Stock | |
50 mg | $2,270 | In Stock | |
100 mg | $2,970 | In Stock |
Description | MRTX-9768 is a synthetic lethal-based inhibitor designed to bind the PRMT5-MTA complex and selectively target MTAP/CDKN2A-deleted tumors. |
Targets&IC50 | Cell proliferation:11 nM(HCT116 MTAP-del cells), Cell proliferation:861 nM(HCT116 MTAP-WT cells), SDMA:3 nM(HCT116 MTAP-del cells), SDMA:544 nM(HCT116 MTAP-WT cells) |
In vitro | MRTX-9768, a potent inhibitor of SDMA and cell proliferation in HCT116 MTAP-del cells (SDMA IC50 3 nM; prolif. IC50 11 nM) with marked selectivity over HCT116 MTAP-WT cells (SDMA IC50 544 nM; prolif. IC50 861 nM). |
In vivo | In xenograft studies, oral administration of MRTX-9768 demonstrates dose-dependent inhibition of SDMA in MTAP-del tumors, with less SDMA modulation observed in bone marrow[1]. |
Molecular Weight | 424.43 |
Formula | C24H17FN6O |
Cas No. | 2629314-68-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | ||||||||||||||||||||||||||||||
Solubility Information | DMSO: 35 mg/mL (82.46 mM) | ||||||||||||||||||||||||||||||
Solution Preparation Table | |||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.